NEXAVAR may cause birth defects or death of an unborn baby. Avoid becoming pregnant while taking NEXAVAR and for at least 2 weeks after stopping your treatment. Men and women should use birth control during and at least 2 weeks after NEXAVAR therapy. Call your doctor right away if you become pregnant. Do not breastfeed while taking NEXAVAR as this medication may be passed through breast milk. Before starting NEXAVAR, tell your doctor if you have allergies; heart problems or chest pain; bleeding or bruising problems. continue reading below »
Surgery is the most common treatment for kidney cancer.1 There are several types of surgery that can be done depending on each individual patient. These include1:
Other therapies are available in addition to surgery. These include1,3:
References: 1. American Cancer Society. Overview: kidney cancer. How is kidney cancer treated? ACS Web site. http://www.cancer.org/docroot/CRI/content/CRI_2_2_4x_Treatment_for_kidney_cancer_22.asp?sitearea=. Updated May 6, 2009. Accessed August 26, 2009. 2. Escudier B, Eisen T, Stadler WM, et al. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol. 2009;27(20):3312-3318. 3. National Cancer Institute, US National Institutes of Health. Renal cell cancer (PDQ®): treatment patient version. NCI Web site. http://www.cancer.gov/cancertopics/pdq /treatment /renalcell/patient/allpages. Updated June 18, 2008. Accessed August 14, 2009.